Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|January 30, 2018
Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor TypesKristina M Ilieva, Anthony Cheung, Silvia Mele, et al.
Oncoimmunology|January 30, 2018
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)Ricarda M Hoffmann, Ben G T Coumbe, Debra H Josephs, et al.
Frontiers in Immunology|April 10, 2018
Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B CellsIsabel Correa, Kristina M Ilieva, Silvia Crescioli, et al.
Cancers|September 10, 2021
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE TreatmentsAlex J McCraw, Jitesh Chauhan, Heather J Bax, et al.
Cancers|April 26, 2020
A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing MelanomaRicarda M Hoffmann, Silvia Crescioli, Silvia Mele, et al.
Mabs|November 27, 2019
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.
Oncoimmunology|August 1, 2022
Enriched circulating and tumor-resident TGF-β+ regulatory B cells in patients with melanoma promote FOXP3+ TregsRobert J Harris, Zena Willsmore, Roman Laddach, et al.
Allergy|August 5, 2024
IgE glycosylation and impact on structure and function: A systematic reviewAlexandra J McCraw, Lais C G F Palhares, Jenifer L Hendel, et al.
Ebiomedicine|April 9, 2019
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesGiulia Pellizzari, Coran Hoskin, Silvia Crescioli, et al.
Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.
Pageof 5